FDA approval sees Orthocell's Remplir enter multi-billion dollar US nerve market

By Proactive Investors / April 07, 2025 / www.youtube.com / Article Link


Orthocell Ltd chairman John van der Wielen talked with Proactive about the company receiving FDA clearance for its nerve repair ...

Recent News

Immediate trigger for crash was new Fed Chairman pick

February 02, 2026 / www.canadianminingreport.com

Gold stocks slump on metal price decline

February 02, 2026 / www.canadianminingreport.com

Is the gold market starting to turn 'irrationally exuberant'?

January 26, 2026 / www.canadianminingreport.com

Gold stocks explode up as equity markets languish

January 26, 2026 / www.canadianminingreport.com

Gold stocks outpace flat large caps

January 19, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok